Autres langues Diadexus, Inc.

Actions

DDXSQ

US25245P2056

Produits pharmaceutiques

Temps Différé OTC Markets			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-

13/08/15	Transcript : Diadexus, Inc., Q2 2015 Earnings Call, Aug 13, 2015
12/05/15	Transcript : diaDexus, Inc., Q1 2015 Earnings Call, May 12, 2015

Autres langues

17/09/21	Diadexus, Inc. Went Out of Business
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.
09/05/18	Motion for Asset Sale Filed by Diadexus, Inc.
01/08/16	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).
29/07/16	Motion for Asset Sale Approved for Diadexus, Inc.
29/07/16	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.
20/07/16	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).
07/07/16	Motion for Asset Sale Filed by Diadexus, Inc.
07/07/16	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.
13/06/16	Diadexus, Inc. Filed for Bankruptcy
10/06/16	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office
23/05/16	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test
30/04/16	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016
19/04/16	Diadexus, Inc. Provides Revenue Guidance for the First Quarter of 2016
18/04/16	Diadexus, Inc. Announces Preliminary Revenue Results for the First Quarter Ended March 31, 2016
29/03/16	Diadexus, Inc. Announces Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2015
29/03/16	Diadexus, Inc. Auditor Raises 'Going Concern' Doubt
18/03/16	Diadexus, Inc. Announces Resignation of Dr. Emilia Zychlinksy as Executive Vice President and Chief Technical Officer, Effective as of April 1, 2016
11/11/15	Diadexus, Inc. Presents New Plac(r) Activity Data from the Regards Study at 2015 American Heart Association Scientific Sessions
26/10/15	Diadexus, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015
14/10/15	Diadexus, Inc. Names Jonathan Ruais as Vice President of Marketing
09/09/15	DiaDexus Signs License Agreement with OriGene Technologies and Wuxi OriGene Biotechnology
04/09/15	Diadexus, Inc. announced that it has received $1 million in funding from OriGene Technologies, Inc..
13/08/15	Diadexus, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2015; Rescinds Revenue Guidance for 2015
29/07/15	Diadexus, Inc. will Change its Ticker to DDXS from DDXS.D